Cypress Capital Group Decreases Stock Holdings in Cardinal Health, Inc. $CAH

Cypress Capital Group reduced its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 53.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,395 shares of the company’s stock after selling 1,589 shares during the period. Cypress Capital Group’s holdings in Cardinal Health were worth $234,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its stake in shares of Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after buying an additional 1,193,983 shares during the period. Northern Trust Corp boosted its holdings in Cardinal Health by 3.5% in the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock valued at $433,012,000 after acquiring an additional 105,154 shares in the last quarter. Wellington Management Group LLP boosted its holdings in Cardinal Health by 1,666.7% in the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after acquiring an additional 2,249,241 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in Cardinal Health by 3.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company’s stock valued at $227,877,000 after purchasing an additional 52,714 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in Cardinal Health by 0.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock worth $171,749,000 after purchasing an additional 7,940 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on CAH shares. Robert W. Baird lifted their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Wells Fargo & Company reiterated an “overweight” rating and set a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Evercore ISI lowered their target price on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Finally, Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research report on Tuesday, August 12th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $166.00.

Cardinal Health Stock Down 1.7%

Shares of CAH opened at $154.26 on Tuesday. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44. The company has a market capitalization of $36.65 billion, a P/E ratio of 23.92, a price-to-earnings-growth ratio of 1.33 and a beta of 0.71. The firm has a 50 day moving average of $152.00 and a 200 day moving average of $151.43.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Insiders Place Their Bets

In other news, insider Ola M. Snow sold 28,151 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares of the company’s stock, valued at $2,298,293.14. The trade was a 64.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michelle D. Greene sold 13,500 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the transaction, the insider owned 14,976 shares in the company, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock worth $40,489,525 in the last quarter. Insiders own 0.12% of the company’s stock.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.